Global experts in hyperthermia therapy gather in one place… Illuminating the present and future of cancer treatment
‘7th IVRA International Medical Conference Indonesia’ held in Jakarta on the 1st
Proof that hyperthermia is becoming a stepping stone for practical application in medical settings
 |
【Health and Welfare News】 An international conference was held where world-renowned experts in the field of hyperthermia gathered to present the results of cancer treatment so far and to shed light on the present and future of hyperthermia as a cancer treatment method.
The ‘7th IVRA (International Virus Research Alliance) International Medical Conference Indonesia’ was held on December 1st at the Grand Ballroom of the JS Luwansa Hotel & Convention Center in Jakarta, Indonesia.
The conference, held under the theme of ‘Hyperthermia in Oncology: Where is Hyperthermia?’, was attended by many world-renowned experts in the field of hyperthermia. Speakers from various countries including Korea, Malaysia, Singapore, Indonesia, and Australia attended. Key speakers included Han Sung-ho, CEO of AdipoLABs, from Korea; Professor Kim Eui-shin (Seoul National University College of Medicine), MD Anderson Professor; Professors Jang Hong-seok and Choi Gyu-hye of Seoul St. Mary’s Hospital; Yoo Seung-mo, President of Yesan Myongji Hospital; Lee Chan-yong, President of Seoul Oncare; and Shin Hyeong-jin, President of Hwaseong EM365.
Also, Dr. Jayendran Dharmaratnam, Mr. Michael Loone, Dr. Kenny Yong Yean sirn from Malaysia, Dr. Brendan Chia Seng Hup, Dr. Deibby Mamahit from Singapore, Prof. Dr. Agus Purwadianto, Dr. Widya Murni from Indonesia, Dr. Taufiq Binjemain from Australia, and about 300 Indonesian cancer treatment experts participated and presented the effectiveness of hyperthermia and treatment cases.
The event was moderated by Dr. Cosphiadi Irawan and Dr. Dr, Demak Lumban Tobing, Prof. Laksono Trisnantoro, Dr. Handoko from Indonesia, and Dr. Zawawi Abdulla from Malaysia, who led the discussion. This conference, which explored the potential of hyperthermia as a cancer treatment method and sought ways to improve the treatment effect and the quality of life of patients through it, was evaluated as an important opportunity to strengthen cooperation between experts from each country by sharing the latest technology and research results. In addition, Korean singer Nora Jo has been volunteering for cancer patients every year and also attended the dinner of this academic seminar to share the same purpose. Regarding this conference, Han Sung-ho, CEO of AdipoLABs, said, “Hyperthermia is rapidly developing as a cancer treatment and is greatly contributing to improving the quality of life of patients.” He continued, “Through this conference, experts from each country shared the latest research and clinical cases, proving that hyperthermia is becoming a stepping stone for establishing itself in the global medical field.” |
 |
Meanwhile, the high-frequency hyperthermia cancer treatment device ‘REMISSION 1℃’ manufactured and sold by AdipoLABs Co., Ltd. was approved by the Ministry of Food and Drug Safety in October 2015 for the purpose of cancer treatment, and has obtained European CE certification, Halal certification, and Malaysian MDA certification. It is a medical device that safely increases body temperature to 42°C through deep frictional heat generated by transmitting 0.46MHz high frequency into the human body, thereby maximizing the effect of hyperthermia treatment to treat cancer.
In particular, the device has a mechanism to generate deep heat through high-frequency current in the human body and necrotize cancer cells that are vulnerable to heat, and is emerging as a new hope for cancer treatment for cancer patients both domestically and internationally.
Source: https://m.whosaeng.com/157097
